Conjugated Linoleic Acid (CLA): A Global Strategic Business Report
San Jose, CA (PRWEB) August 24, 2011
Rising health concerns among consumers and inclination to look good through healthy dietary habits have sparked demand for functional foods and nutritional supplements. One of the most prominent nutritional and dietary supplements gaining impetus globally is conjugated linoleic acid (CLA), perceived as a panacea for several modern-day ills. The polyunsaturated fatty acid has been around for more than three decades now, and over the last few years has gained considerable ground as an effective weight management ingredient. Until a few years ago CLA was largely used as dietary supplement, but with the increasing demand for fortified food products, CLA is finding usage as a functional ingredient in the food & beverage industry. The recent spurt in interest is credited to a large body of clinical evidence pointing to CLA’s weight control properties.
CLA is emerging as a potential ingredient in the weight management market worldwide, as obesity rates are on the rise not only in the high income western countries by also in developing countries. In addition to the primary weight loss solution, CLA is also known for other medical benefits such as cancer fighting properties, muscle strengthening, improved metabolic functioning and blood sugar regulation among others. CLA is also witnessing heightened usage in the animal feed industry, primarily for enhancing the quality of meat and dairy products and protection of animals against diseases. The commercially available CLA, sold as an ingredient, is primarily sourced from natural safflower/sunflower oil. This ‘natural’ characteristic of the ingredient is further expected to appeal to a large number of consumers who are increasingly turning away from artificial or synthetic products.
The market for CLA although robustly positioned as a niche ingredient in the dietary supplements market, is still in a nascent stage of development, particularly with respect to other end-use areas, namely functional foods and animal feed. The US and Europe represent the leading markets for CLA, collectively accounting for a majority share of the global market. With more than half the population (65%) in the US regarded as overweight, it is no surprise that the region is fuelling the maximum demand for CLA in the present scenario. Post the GRAS (Generally Recognized as Safe) status from the US FDA, CLA fortified foods have already hit the market shelves in the region. Although CLA has a stronghold in the European market, its usage in food products relies solely on the Novel Food approval issued by regulatory authority in the country. In addition, lack of sufficient scientific backing for the health claims, poor consumer awareness, unnecessary hype, low turnaround time and consumer skepticism are few of the potential hazards, challenging CLA’s widespread acceptance in all market worldwide.
The US dominates the global scenario as the single largest market for conjugated linoleic acid, as stated by the new research report on Conjugated Linoleic Acid (CLA). High obesity rates and wide consumer acceptance make the CLA ingredient a viable option in the nutritional supplements market in the US. The Asia-Pacific market presently accounts for a minor share of the global market, but is expected to display potential for rapid growth and development. Increasing adoption of western lifestyles, unhealthy eating habits and rising number of overweight individuals pose potential health risks and can be a burden to the country’s exchequer. The CLA market in Asia-Pacific is projected to witness fast track growth at a sturdy CAGR of more than 18% through 2017.
The global conjugated linoleic acid (CLA) market is largely dominated by a handful of deep pocketed, international players who are the primary trendsetters and have a major presence in several countries worldwide. The rest of the market is highly fragmented with several medium and small players competing for stronger positioning and bargaining power. Key participants profiled in the report include Aiko Natural Products Co., Ltd., Cognis, Dalian Innobioactives Co., Ltd, Jarrow Formulas, Lipid Nutrition, Natures Way, NOW Foods, Vitae Caps, S.A, and Zhongshan Unicare Natural Medicine Co. Ltd.
The research report titled “Conjugated Linoleic Acid (CLA): A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of industry overview, growth drivers, issues & trends, end-use analysis, product overview, recent industry activity and profiles of market players worldwide. Market Analytics and overview is provided in value (US$) terms for major geographic markets such as US, Canada, Japan, Europe, Asia-Pacific and Rest of World.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Conjugated_Linoleic_Acid_CLA_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/